首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名：Lancet diabetes & endocrinology

缩写：

ISSN：2213-8587

e-ISSN：2213-8595

IF/分区：41.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2699条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
South Africa to produce insulin for Africa in 2024 [0.03%] 南非计划于2024年为非洲生产胰岛素
Munyaradzi Makoni Munyaradzi Makoni
The lancet. Diabetes & endocrinology. 2024 Jan;12(1):18. DOI:10.1016/S2213-8587(23)00357-1 2024
Correction to Lancet Diabetes Endocrinol 2023; 11: 798-810 [0.03%] 柳叶刀糖尿病和内分泌学杂志2023; 11: 798-810的勘误表
Published Erratum The lancet. Diabetes & endocrinology. 2024 Jan;12(1):e1. DOI:10.1016/S2213-8587(23)00350-9 2024
Correction to Lancet Diabetes Endocrinol 2023; 11: 720-30 [0.03%] 柳叶刀糖尿病和内分泌学（2023）11：720-30的更正
Published Erratum The lancet. Diabetes & endocrinology. 2023 Dec;11(12):e14. DOI:10.1016/S2213-8587(23)00319-4 2023
Iodine status in Iran: from deficient to replete [0.03%] 伊朗的碘状况：从缺乏到充足
Fereidoun Azizi,Hossein Delshad,Mehdi Hedayati et al. Fereidoun Azizi et al.
The lancet. Diabetes & endocrinology. 2023 Dec;11(12):903-904. DOI:10.1016/S2213-8587(23)00318-2 2023
Metabolic non-communicable diseases in India: time to act - Authors' reply [0.03%] 印度代谢性非传染性疾病：是时候采取行动了——作者回应
Ranjit Mohan Anjana,Ranjit Unnikrishnan,Rajendra Pradeepa et al. Ranjit Mohan Anjana et al.
The lancet. Diabetes & endocrinology. 2023 Dec;11(12):898-899. DOI:10.1016/S2213-8587(23)00296-6 2023
Metabolic non-communicable diseases in India: time to act [0.03%] 印度代谢性非传染性疾病：是时候采取行动了
Shifa Habeeb,Kavumpurathu Raman Thankappan Shifa Habeeb
The lancet. Diabetes & endocrinology. 2023 Dec;11(12):897-898. DOI:10.1016/S2213-8587(23)00298-X 2023
Metabolic non-communicable diseases in India: time to act [0.03%] 印度代谢性非传染性疾病：是时候采取行动了
Shikha Nag,Suyesh Shrivastava,Tapas Chakma Shikha Nag
The lancet. Diabetes & endocrinology. 2023 Dec;11(12):896-897. DOI:10.1016/S2213-8587(23)00297-8 2023
Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial - Authors' reply [0.03%] 降糖药物疗效的比较：利用实际数据模拟四组目标临床试验——作者回复
Yan Xie,Ziyad Al-Aly Yan Xie
The lancet. Diabetes & endocrinology. 2023 Dec;11(12):895-896. DOI:10.1016/S2213-8587(23)00292-9 2023
Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial [0.03%] 降糖药物疗效比较：利用真实数据模拟四组目标试验研究
Mirac Vural Keskinler,Ozge Telci Caklili,Aytekin Oguz Mirac Vural Keskinler
The lancet. Diabetes & endocrinology. 2023 Dec;11(12):894. DOI:10.1016/S2213-8587(23)00290-5 2023
Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial [0.03%] 降糖药物疗效的比较：利用真实世界数据模拟四组目标对照试验
Antonio Ceriello,Francesco Prattichizzo,Cesare Celeste Berra et al. Antonio Ceriello et al.
The lancet. Diabetes & endocrinology. 2023 Dec;11(12):894-895. DOI:10.1016/S2213-8587(23)00289-9 2023